Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Tax Provisions of -$2.6 million for Q1 2026, down 702.11% year-over-year from $427000.0 in Q1 2025, and down 168.82% quarter-over-quarter from $3.7 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Tax Provisions for 9 consecutive years, with -$2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 702.11% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at $1.2 million (up 129.85% YoY), while the FY2025 annual figure was $4.2 million, up 203.06% from the prior year.
- Tax Provisions fell to -$2.6 million in Q1 2026 per XENE's latest filing, from $3.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $3.7 million in Q4 2025 and bottomed at -$3.8 million in Q4 2024.
- Historically, Tax Provisions has averaged -$151529.4 across 5 years, with a median of -$205000.0 in 2023.
- Annual changes were most pronounced in 2024 — Tax Provisions sank 1777.07% — and 2025, when it surged 311.56%.
- Xenon Pharmaceuticals' Tax Provisions stood at $1.2 million in 2022, then sank by 117.33% to -$205000.0 in 2023, then tumbled by 1777.07% to -$3.8 million in 2024, then surged by 197.09% to $3.7 million in 2025, then tumbled by 168.82% to -$2.6 million in 2026.
- Business Quant data shows XENE's Tax Provisions at -$2.6 million in Q1 2026, $3.7 million in Q4 2025, and $677000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | -585,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -585,000.00 |
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 677,000.00 |
| Jun 30, 2025 | -626,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 412,000.00 |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -157,000.00 |
| Jun 30, 2023 | -220,000.00 |
| Mar 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | -587,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Mar 31, 2022 | -394,000.00 |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | -205,000.00 |